GeneHealth - Your precision medicine

Syphilis

Disease Details

Family Health Simplified

Buy Membership

Description: Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum, characterized by distinct stages and varying symptoms, including sores, rashes, and potential long-term complications if left untreated.
Type: Syphilis is an infectious disease caused by the bacterium *Treponema pallidum*. It is not genetically transmitted; instead, it is primarily transmitted through direct sexual contact with infectious lesions, from mother to child during childbirth (congenital syphilis), or less commonly through transfusion of contaminated blood.
Signs And Symptoms: Syphilis can present in one of four different stages: primary, secondary, latent, and tertiary, and may also occur congenitally. It was referred to as "the great imitator" by Sir William Osler due to its varied presentations.
Prognosis: Syphilis is a bacterial infection typically spread through sexual contact, caused by the bacterium Treponema pallidum. The prognosis of syphilis depends significantly on the stage at which it is diagnosed and treated:

1. **Primary and Secondary Stages**: If diagnosed and treated early with appropriate antibiotics (usually penicillin), syphilis has an excellent prognosis. Most people recover fully without any long-term health issues.

2. **Latent Stage**: During this stage, the bacteria remain in the body without causing symptoms. Early latent syphilis (within a year of infection) can still be treated effectively, but the risk of complications increases if left untreated and detection may be more challenging.

3. **Tertiary Stage**: Without treatment, syphilis can progress to the tertiary stage, which can occur years or even decades after the initial infection. This stage can result in severe complications, including damage to the heart, brain, nerves, eyes, and other organs. The prognosis in this stage is more guarded, as some of the damage may be irreversible, though antibiotics can still halt further progression.

Early detection and treatment are crucial for improving outcomes and preventing complications associated with syphilis.
Onset: Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum.

- Onset: The initial symptoms of syphilis typically appear 10 days to 3 months after exposure. The first stage usually presents with a painless sore or ulcer (chancre) at the site of infection, followed by additional stages if untreated.

- NAN: Syphilis does not involve NAN (Nucleic Acid Nanotechnology); thus, this aspect is not applicable to the disease.
Prevalence: Prevalence of syphilis varies significantly by region, population, and over time. It is a global public health concern:

1. **Global Prevalence**: According to the World Health Organization (WHO), there were an estimated 6 million new cases of syphilis among adults worldwide in 2016.

2. **United States**: The Centers for Disease Control and Prevention (CDC) reported that in 2019, there were 38,992 reported new cases of primary and secondary syphilis, which are the most infectious stages of the disease.

Rates are generally higher in men than in women, particularly among men who have sex with men (MSM). However, syphilis rates are increasing overall, including among heterosexual populations and women, which raises concerns about congenital syphilis.

Please check the latest reports from respective health organizations for the most up-to-date figures.
Epidemiology: In 2012, about 0.5% of adults were infected with syphilis, with 6 million new cases. In 1999, it is believed to have infected 12 million additional people, with greater than 90% of cases in the developing world. It affects between 700,000 and 1.6 million pregnancies a year, resulting in spontaneous abortions, stillbirths, and congenital syphilis. During 2015, it caused about 107,000 deaths, down from 202,000 in 1990. In sub-Saharan Africa, syphilis contributes to approximately 20% of perinatal deaths. Rates are proportionally higher among intravenous drug users, those who are infected with HIV, and men who have sex with men. In the United States about 55,400 people are newly infected each year as of 2014. African Americans accounted for almost half of all cases in 2010. As of 2014, syphilis infections continue to increase in the United States. In the United States as of 2020, rates of syphilis have increased by more than threefold; in 2018 approximately 86% of all cases of syphilis in the United States were in men. In 2021, preliminary CDC data illustrated that 2,677 cases of congenital syphilis were found in the population of 332 million in the United States.Syphilis was very common in Europe during the 18th and 19th centuries. Flaubert found it universal among 19th-century Egyptian prostitutes. In the developed world during the early 20th century, infections declined rapidly with the widespread use of antibiotics, until the 1980s and 1990s. Since 2000, rates of syphilis have been increasing in the US, Canada, the UK, Australia and Europe, primarily among men who have sex with men. Rates of syphilis among US women have remained stable during this time, while rates among UK women have increased, but at a rate less than that of men. Increased rates among heterosexuals have occurred in China and Russia since the 1990s. This has been attributed to unsafe sexual practices, such as sexual promiscuity, prostitution, and decreasing use of barrier protection.Left untreated, it has a mortality rate of 8% to 58%, with a greater death rate among males. The symptoms of syphilis have become less severe over the 19th and 20th centuries, in part due to widespread availability of effective treatment, and partly due to virulence of the bacteria. With early treatment, few complications result. Syphilis increases the risk of HIV transmission by two to five times, and coinfection is common (30–60% in some urban centers). In 2015, Cuba became the first country to eliminate mother-to-child transmission of syphilis.
Intractability: Syphilis is not considered intractable. It is a bacterial infection caused by Treponema pallidum and can be effectively treated, especially in its early stages, with appropriate antibiotic therapy, typically penicillin. Early diagnosis and treatment are crucial for a favorable outcome, though later stages can cause more severe health issues which might be more challenging to manage.
Disease Severity: Syphilis can range from mild to severe depending on the stage of the disease. The severity increases if not treated promptly.

1. **Primary Stage:** Characterized by painless sores at the site of infection.
2. **Secondary Stage:** Can cause skin rashes, mucous membrane lesions, and flu-like symptoms.
3. **Latent Stage:** No symptoms, but the infection remains in the body.
4. **Tertiary Stage:** Can cause severe medical problems affecting the heart, brain, and other organs, potentially becoming life-threatening.
Healthcare Professionals: Disease Ontology ID - DOID:4166
Pathophysiology: Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. The pathophysiology of syphilis involves several stages:

1. **Primary Syphilis**: The initial infection typically occurs through direct contact with a syphilitic sore (chancre) at the site of inoculation, usually the genitalia, anus, or mouth. The bacteria penetrate the mucous membranes or microscopic abrasions in the skin, leading to local multiplication and a chancre formation.

2. **Secondary Syphilis**: If untreated, the infection disseminates through the bloodstream, reaching various tissues and organs. This stage is characterized by a skin rash, mucous membrane lesions, and generalized lymphadenopathy. The bacteria activate the immune response, which manifests as systemic symptoms.

3. **Latent Syphilis**: After the secondary symptoms resolve, the infection enters a latent phase, where the bacteria remain in the body without causing symptoms. This phase can last for years and is divided into early latent (within the first year) and late latent syphilis (after the first year).

4. **Tertiary Syphilis**: Without treatment, syphilis can progress to this late stage, which can occur years to decades after the initial infection. It can cause severe damage to multiple organ systems, including the cardiovascular system (e.g., aortic aneurysm), central nervous system (neurosyphilis), and other tissues, leading to gummas (soft, tumor-like growths).

Throughout its course, T. pallidum evades the immune system by altering its surface proteins, which complicates the immune response and contributes to the disease's progression. Effective antibiotic treatment, typically with penicillin, is crucial at all stages to eliminate the bacteria and prevent complications.
Carrier Status: In the context of syphilis, the term "carrier status" is not typically used in the same way it might be for other infections. Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. Unlike some other diseases, individuals with syphilis are considered infected and symptomatic or asymptomatic, rather than carriers. Even if asymptomatic, they can still transmit the disease to others. Proper diagnosis and treatment are critical to prevent transmission and complications.
Mechanism: Syphilis is a sexually transmitted infection caused by the bacterium *Treponema pallidum*. The mechanism of syphilis involves multiple stages:

1. **Entry and Initial Infection**: The bacterium enters the body through mucous membranes or breaks in the skin, typically during sexual contact.
2. **Primary Syphilis**: *T. pallidum* multiplies at the site of entry and forms a sore called a chancre. This sore is usually painless and appears 2-6 weeks post-infection.
3. **Secondary Syphilis**: The bacteria disseminate through the bloodstream, leading to systemic symptoms like skin rashes, mucous membrane lesions, fever, and swollen lymph nodes.
4. **Latent Syphilis**: The infection enters a latent phase where no symptoms are present, but the bacterium remains in the body.
5. **Tertiary Syphilis**: If untreated, the infection can progress to this stage years later, causing severe damage to organs such as the heart, brain, and nerves.

### Molecular Mechanisms

1. **Adherence and Invasion**: *T. pallidum* uses outer membrane proteins to adhere to host cells and extracellular matrix components. This facilitates its invasion into host tissues.
2. **Immune Evasion**: The bacterium has a sparse outer membrane with few exposed surface proteins, helping it avoid detection by the immune system. Additionally, it is capable of antigenic variation, changing its surface protein expression to evade the immune response.
3. **Motility**: *T. pallidum* is a spirochete, meaning it has a spiral shape and uses axial filaments (endoflagella) to move in a corkscrew-like manner. This unique motility helps it penetrate mucous membranes and tissues.
4. **Tissue Damage**: The bacteria produce lytic enzymes such as hyaluronidase, which degrade connective tissue components and facilitate tissue invasion. In the tertiary stage, the immune response to persistent infection can cause significant tissue damage.
5. **Host Immune Response**: The immune response to *T. pallidum* involves both humoral (antibody-mediated) and cellular (T-cell-mediated) responses. However, the bacterium's ability to persist in immune-privileged sites (e.g., the central nervous system) complicates eradication.

Understanding these mechanisms is crucial for developing targeted treatments and preventive strategies against syphilis.
Treatment: Syphilis is primarily treated with antibiotics. The standard treatment is an intramuscular injection of penicillin G benzathine. The dosage and duration depend on the stage of the infection:

1. **Primary, Secondary, and Early Latent Syphilis**: A single dose of 2.4 million units of penicillin G benzathine.
2. **Late Latent Syphilis or Tertiary Syphilis**: Three doses of 2.4 million units of penicillin G benzathine at weekly intervals.

For patients allergic to penicillin, alternative antibiotics such as doxycycline or tetracycline may be used, though these require longer courses of treatment. It is crucial for individuals to complete the full course of antibiotics and follow up with their healthcare provider to ensure the infection is fully treated. Sexual partners should also be informed, tested, and treated if necessary to prevent reinfection and further transmission.
Compassionate Use Treatment: Compassionate use treatment for syphilis is typically reserved for patients who cannot be treated with the standard regimen of antibiotics. The mainstay treatment for syphilis, including for various stages, is benzathine penicillin G. However, for compassionate use, particularly in patients with severe penicillin allergy, second-line treatments such as doxycycline or tetracycline may be considered. Ceftriaxone has also been used off-label in some cases.

Experimental treatments or those being researched may include alternative antibiotics or adjunctive therapies, but currently, no widely recognized experimental treatment replaces penicillin. Research is ongoing to identify new therapeutic agents and strategies, particularly for strains that might develop resistance to standard treatments.
Lifestyle Recommendations: For syphilis, lifestyle recommendations primarily focus on prevention, early detection, and treatment adherence:

1. **Safe Sexual Practices**: Use condoms consistently and correctly during sexual activity to reduce the risk of transmission.
2. **Regular Testing**: Get regularly tested for sexually transmitted infections (STIs), especially if you have multiple sexual partners.
3. **Prompt Treatment**: Seek medical advice and treatment immediately if you suspect an infection. Syphilis is curable with appropriate antibiotics, typically penicillin.
4. **Notifying Partners**: Inform all recent sexual partners if you are diagnosed so they can also get tested and treated if necessary.
5. **Avoiding Sharing Needles**: If you use injectable drugs, do not share needles or syringes with others.

Early recognition and treatment are crucial to prevent complications and the spread of syphilis.
Medication: Syphilis is commonly treated with antibiotics. The preferred medication for all stages of syphilis is intramuscular benzathine penicillin G. For those allergic to penicillin, alternative antibiotics like doxycycline or azithromycin may be used. Early-stage syphilis typically requires a single dose of penicillin, while later stages might require additional doses.
Repurposable Drugs: For syphilis, penicillin remains the most effective treatment, specifically benzathine penicillin G. While other antibiotics like doxycycline or tetracycline can be considered as alternatives for those allergic to penicillin, there's no widely accepted repurposable drug currently used for syphilis. Researchers continually explore other treatment options, but penicillin remains the standard due to its proven efficacy.
Metabolites: Syphilis is a bacterial infection caused by Treponema pallidum. When it comes to metabolites, during infection, the host's immune response and the pathogen's metabolism can produce various small molecules. Specific metabolites related to syphilis infection might include lipids, amino acids, and nucleotides, but there are no unique, identifiable signature metabolites used routinely for its diagnosis. The primary methods for diagnosing syphilis include serological tests such as the Rapid Plasma Reagin (RPR) test and the Fluorescent Treponemal Antibody Absorption (FTA-ABS) test, rather than metabolic profiling.
Nutraceuticals: Nutraceuticals are not typically part of the standard treatment for syphilis. The primary treatment for syphilis is antibiotic therapy, specifically penicillin. Nutraceuticals, which can include vitamins, minerals, and other natural supplements, do not have proven efficacy in treating this bacterial infection. It is essential to consult with a healthcare provider for appropriate diagnosis and treatment.
Peptides: Syphilis is a bacterial infection caused by *Treponema pallidum*. Peptides can be explored for diagnostic purposes, vaccine development, and treatment targets. Nanotechnology can be applied for improved diagnostics, drug delivery, and enhanced imaging techniques to study the infection.